Lowering LDL in patients with heart disease: How aggressive should you be?

Thomas A. Pearson, MD, PhD
Chairman, Department of Community and Preventive Medicine and Albert D. Kaiser Professor, University of Rochester Medical Center, New York

Fredric J. Pashkow, MD
Medical director, Heart Institute, Queen’s Medical Center, Honolulu, Hawaii; Adjunct staff, Cleveland Clinic

Addresses: Thomas A. Pearson, MD, PhD, Department of Community and Preventive Medicine, PO Box 644, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Fredric J. Pashkow, MD, Medical Director, Heart Institute, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813

Dr. Pearson has indicated that he has received grant or research support and serves as a consultant and a member of the speakers' bureau for several companies that manufacture lipid-lowering drugs.

Dr. Pashkow has also indicated that he serves on the speakers' bureau of several of these companies.

Thomas A. Pearson, MD, PhD
Chairman, Department of Community and Preventive Medicine and Albert D. Kaiser Professor, University of Rochester Medical Center, New York

Fredric J. Pashkow, MD
Medical director, Heart Institute, Queen’s Medical Center, Honolulu, Hawaii; Adjunct staff, Cleveland Clinic

Addresses: Thomas A. Pearson, MD, PhD, Department of Community and Preventive Medicine, PO Box 644, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Fredric J. Pashkow, MD, Medical Director, Heart Institute, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813

Dr. Pearson has indicated that he has received grant or research support and serves as a consultant and a member of the speakers' bureau for several companies that manufacture lipid-lowering drugs.

Dr. Pashkow has also indicated that he serves on the speakers' bureau of several of these companies.

Thomas A. Pearson, MD, PhD
Chairman, Department of Community and Preventive Medicine and Albert D. Kaiser Professor, University of Rochester Medical Center, New York

Fredric J. Pashkow, MD
Medical director, Heart Institute, Queen’s Medical Center, Honolulu, Hawaii; Adjunct staff, Cleveland Clinic

Addresses: Thomas A. Pearson, MD, PhD, Department of Community and Preventive Medicine, PO Box 644, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Fredric J. Pashkow, MD, Medical Director, Heart Institute, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813

Dr. Pearson has indicated that he has received grant or research support and serves as a consultant and a member of the speakers' bureau for several companies that manufacture lipid-lowering drugs.

Dr. Pashkow has also indicated that he serves on the speakers' bureau of several of these companies.